Found 183 matching trials
Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
PHASE2The purpose of this study is to observe and evaluate the efficacy and safet...
Location
The First Affiliated Hospital of Zhengzhou University
A Study to Evaluate the Safety and Tolerability of Using SHR-1210 by Advanced Solid Tumor Subjects
PHASE1This is an open-label, non-randomized, dose escalation phase I trial to eva...
Location
Cancer Hospital Chinese Academy of Medical Sciences
Neoadjuvant Immunochemotherapy in PD-L1-negative LACC
PHASE2This is a multicenter, prospective, single-arm, phase 2 clinical trial desi...
Location
Anhui Provincial Cancer Hospital
A Study of SHR-1210 in Combination With Carboplatin + Paclitaxel in Subjects With Squamous NSCLC
PHASE3This study is a randomized, placebo-controlled, double-blind, multicenter p...
Location
Anhui Provincial Hospital
A Study to Evaluate SHR-1210 in Subjects With Advanced HCC
PHASE2This a randomized controlled Phase 2/3 study to evaluate the efficacy and s...
Location
The First Affiliated Hospital of Bengbu Medical College
Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer
PHASE1The purpose of this study is to observe and preliminary explore the efficac...
Location
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer
PHASE2This study is a prospective, single-center, open-label, umbrella-shaped pha...
Location
Cancer Hospital Affiliated to Fudan University
A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC
PHASE2This an open-label,Non-Randominzed Phase 2 study to evaluate the Safety and...
Location
The Second Affiliated Hospital Of Anhui Medical University
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
PHASE2The purpose of this study is to establish a prospective, single-center plat...
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma
PHASE2The objective of this study is to evaluate the efficacy and safety of cryoa...
Location
Fudan University Shanghai Cancer Center